These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14968353)

  • 41. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measuring of the heparin leakage into the circulation from central venous catheters--an in vivo study.
    Markota I; Markota D; Tomic M
    Nephrol Dial Transplant; 2009 May; 24(5):1550-3. PubMed ID: 19075195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term silastic catheters and chest pain.
    Passaro ME; Steiger E; Curtas S; Seidner DL
    JPEN J Parenter Enteral Nutr; 1994; 18(3):240-2. PubMed ID: 8065000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.
    Manfredi JA; Wall RP; Sane DC; Braden GA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Management of catheter-related upper extremity deep vein thrombosis].
    Linnemann B; Lindhoff-Last E
    Zentralbl Chir; 2013 Dec; 138 Suppl 2():e86-94. PubMed ID: 23575524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do bevacizumab solutions interact with silicone or polyurethane catheters during an infusion through implantable venous access ports?
    Tokhadzé N; Chennell P; Cueff R; Sautou V
    J R Soc Interface; 2019 Sep; 16(158):20180721. PubMed ID: 31551048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples.
    Lorenz RG; Garrett N; Turk JW; Scott MG
    Transplantation; 1991 Dec; 52(6):1109-10. PubMed ID: 1750077
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retention of lepirudin at the tip of a silicone catheter: a better catheter flush solution?
    Horne MK; Inkellis E
    Support Care Cancer; 2004 Apr; 12(4):278-81. PubMed ID: 14968353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices.
    Horne MK; McCloskey DJ; Calis K; Wesley R; Childs R; Kasten-Sportes C
    Pharmacotherapy; 2006 Sep; 26(9):1262-7. PubMed ID: 16945048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antithrombin activity of lepirudin adsorbed to silicone (polydimethylsiloxane) tubing.
    Horne MK; Brokaw KJ
    Thromb Res; 2003; 112(1-2):111-5. PubMed ID: 15013282
    [No Abstract]   [Full Text] [Related]  

  • 52. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
    Shanks RM; Sargent JL; Martinez RM; Graber ML; O'Toole GA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2247-55. PubMed ID: 16627606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of relative perforating potential of central venous catheters: comparison of materials, selected models, number of lumens, and angles of incidence to simulated membrane.
    Gravenstein N; Blackshear RH
    J Clin Monit; 1991 Jan; 7(1):1-6. PubMed ID: 1999693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Shaughnessy SG; Anand SS; Halperin JL; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 2001 Jan; 119(1 Suppl):64S-94S. PubMed ID: 11157643
    [No Abstract]   [Full Text] [Related]  

  • 56. Peripheral venous access ports: outcomes analysis in 109 patients.
    Bodner LJ; Nosher JL; Patel KM; Siegel RL; Biswal R; Gribbin CE; Tokarz R
    Cardiovasc Intervent Radiol; 2000; 23(3):187-93. PubMed ID: 10821892
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.